4.65
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché AVXL Giù?
Forum
Previsione
Frazionamento azionario
Anavex Life Sciences Corporation Azioni (AVXL) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
8.01%
1.079
|
0.999 | 1.075 | 1.21 | 1.394 |
|
|
37.46%
6.782
|
10.84 | 14.46 | 12.51 | 13.59 |
| Benefits Costs and Expenses |
100.00%
-
|
51.05 | - | - | - |
| Costs And Expenses |
15.40%
7.861
|
6.812 | 15.53 | 13.72 | 14.99 |
| Provision For Loan, Lease, And Other Losses |
-
|
- | - | - | - |
| Operating Income/Loss |
37.46%
-6.782
|
-10.84 | -14.46 | -12.51 | -13.59 |
| Net Interest Income/Expense |
8.01%
1.079
|
0.999 | 1.075 | 1.21 | 1.394 |
| Nonoperating Income/Loss |
10.03%
1.119
|
1.017 | 1.216 | 1.317 | 1.481 |
| Income/Loss From Continuing Operations Before Tax |
102.16%
1.079
|
-50.06 | 1.075 | 1.21 | 1.394 |
| Income/Loss From Continuing Operations After Tax |
42.19%
-5.681
|
-9.827 | -13.24 | -11.20 | -12.11 |
|
|
42.19%
-5.681
|
-9.827 | -13.24 | -11.20 | -12.11 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
43,616%
89.03
|
0.2037 | 85.38 | 85.07 | 84.81 |
| Diluted Average Shares |
43,616%
89.03
|
0.2037 | 85.38 | 85.07 | 84.81 |
| Basic Earnings Per Share |
45.45%
-0.06
|
-0.11 | -0.16 | -0.13 | -0.14 |
| Diluted Earnings Per Share |
45.45%
-0.06
|
-0.11 | -0.16 | -0.13 | -0.14 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):